<?xml version="1.0" encoding="UTF-8"?>
<ref id="ppat.1008156.ref056">
 <label>56</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Benavente</surname>
   <given-names>Y</given-names>
  </name>, 
  <name>
   <surname>Mbisa</surname>
   <given-names>G</given-names>
  </name>, 
  <name>
   <surname>Labo</surname>
   <given-names>N</given-names>
  </name>, 
  <name>
   <surname>Casabonne</surname>
   <given-names>D</given-names>
  </name>, 
  <name>
   <surname>Becker</surname>
   <given-names>N</given-names>
  </name>, 
  <etal>et al</etal> (
  <year>2011</year>) 
  <article-title>Antibodies against lytic and latent Kaposi's sarcoma-associated herpes virus antigens and lymphoma in the European EpiLymph case-control study</article-title>. 
  <source>Br J Cancer</source>
  <volume>105</volume>: 
  <fpage>1768</fpage>â€“
  <lpage>1771</lpage>. 
  <pub-id pub-id-type="doi">10.1038/bjc.2011.392</pub-id>
  <?supplied-pmid 21952625?>
  <pub-id pub-id-type="pmid">21952625</pub-id>
 </mixed-citation>
</ref>
